Kellye Dunn News Today

Los angeles — Scientists have developed an antibody treatment that shows promise in blocking the potentially deadly effects of fentanyl for nearly a month, raising hopes for a new tool

Scientists say that giving an infusion of monoclonal antibodies has shown promise in blocking the potentially deadly effects of fentanyl for nearly a month, raising hopes for a new tool to combat overdoses.

Scientists say that giving an infusion of monoclonal antibodies has shown promise in blocking the potentially deadly effects of fentanyl for nearly a month, raising hopes for a new tool to combat overdoses.

Medical professor Kelly E. Dunn told Newsweek there is "no empirical or clinical evidence" to show that touching fentanyl could lead to poisoning.

Rainbow fentanyl—regular fentanyl dyed with food coloring—is an opioid drug responsible for 80 per cent of all overdose deaths in New York City.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Press release content from PR Newswire. The AP news staff was not involved in its creation.